ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 118

Colour Doppler Sonography of the Knee Joint: A Useful Tool to Discriminate Arthritis From Osteoarthritis ?

Wolfgang Hartung1, Nelly Beitinger2, Boris P. Ehrenstein1, Christian Lüring3, Joachim Grifka4, Benno Schreiner4, Martina Müller5 and Martin Fleck1, 1Rheumatology & Clinical Immunology, Asklepios Clinic Bad Abbach, Bad Abbach, Germany, 2Rheumatology & Clinical Immunology, Asklepios Klinikum Bad Abbach, Bad Abbach, Germany, 3Orthopaedic and Trauma Surgery, Universitiy Clinic Aachen, Aachen, Germany, 4Orthopedic Surgery, University of Regensburg, Bad Abbach, Germany, 5Clinic for Internal Medicine I, University Clinic Regensburg, Regensburg

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Knee, osteoarthritis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound, Nuclear Medicine and Fluorescence Imaging

Session Type: Abstract Submissions (ACR)

Colour Doppler sonography of the knee joint: A useful tool to discriminate Arthritis from Osteoarthritis ?

Background/Purpose:

To determine the diagnostic value of Colour Doppler ultrasound (CDUS) in patients with inflammatory arthritis (IA) versus osteoarthritis (OA) of the knee joint.

Methods:

Standardized CDUS examinations have been performed in 111 knee joints of 106 patients (70 female, 36 male) presenting with severe OA (n=72) or confirmed IA (n=39) of one or both knee joints, to determine the degree of synovial inflammation in a semiquantitative fashion. To definitely distinguish inflammatory from non-inflammatory disease, synovial fluid has been obtained from every patient within 24 hours after sonography and analyzed synovial fluids containing up to 1000 white blood cells (wbc)/ul were considered non-inflammatory, whereas 5000 or more wbc/ul have been classified as inflammatory,  respectively.

Results:

The CDUS sum score of OA patients was determined at 3.3 (range 0-8). In contrast, IA patients exhibited significantly elevated synovitis scores  at 5.3  (range 3-9) (p < 0.001). However, high synovial CDUS activity could be observed in OA patients sporadically. Therefore, there is no definitive CDUS threshold that clearly separates OA from IA patients.    

Conclusion:

CDUS is a valuable instrument to assist clinicians in distinguishing OA from IA of the knee, but nevertheless should always interpreted within the clinical context.

Table 1: Mean CDUS scores of the patients with osteoarthritis vs. arthritis of the knee.

Scan OA patients (n = 73)

IA patients (n = 39)

suprapatellar

0.14 (0-2)

0.64 (0-2)

infrapatellar

0.14 (0-2)

0.44 (0-2)

medial longitudinal

1.2 (0-3)

2.0 (1-3)

lateral longitudinal

2.0 (0-3)

2.3 (1-3)

Total score

3.3 (0-8)

5.3 (3-9)**

 OA = Osteoarthritis, IA = inflammatory arthritis of the knee, ** (Chi square test: p value < 0.001).


Disclosure:

W. Hartung,

Abbott Immunology Pharmaceuticals,

5,

Pfizer Inc,

5;

N. Beitinger,
None;

B. P. Ehrenstein,

Abbott Immunology Pharmaceuticals,

5,

Pfizer Inc,

5,

Roche Pharmaceuticals,

5;

C. Lüring,
None;

J. Grifka,
None;

B. Schreiner,
None;

M. Müller,
None;

M. Fleck,

Abbott Immunology Pharmaceuticals,

5,

Roche Pharmaceuticals,

5,

Pfizer Inc,

5.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/colour-doppler-sonography-of-the-knee-joint-a-useful-tool-to-discriminate-arthritis-from-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology